Recombinant interleukin-1-beta
Term · Oncology and biomedicine · MLC-T-ONC-016438
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous protein cytokine interleukin 1 (IL-1)-beta. Produced by monocytes and activated macrophages, endogenous mature IL-1 is generated through proteolytic cleavage by proteases such as IL-1-beta converting enzyme (ICE). This agent promotes angiogenesis, fibroblast proliferation, and neutrophil chemotaxis; it also regulates the functions of lymphocytes and epithelial cells and is involved in the 'acute phase response' to infection.
| Identifier | MLC-T-ONC-016438 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | IL-1-b |
| Synonyms | interleukin-1-beta |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016438",
"term": "Recombinant interleukin-1-beta",
"field": "Oncology and biomedicine",
"definition": "A recombinant therapeutic agent which is chemically identical to or similar to the endogenous protein cytokine interleukin 1 (IL-1)-beta. Produced by monocytes and activated macrophages, endogenous mature IL-1 is generated through proteolytic cleavage by proteases such as IL-1-beta converting enzyme (ICE). This agent promotes angiogenesis, fibroblast proliferation, and neutrophil chemotaxis; it also regulates the functions of lymphocytes and epithelial cells and is involved in the 'acute phase response' to infection.",
"abbreviation": "IL-1-b",
"synonyms": [
"interleukin-1-beta"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/recombinant-interleukin-1-beta/"
}
Record 14,184 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.